Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder.
Lecavalier L, Wood JJ, Halladay AK, Jones NE, Aman MG, Cook EH, Handen BL, King BH, Pearson DA, Hallett V, Sullivan KA, Grondhuis S, Bishop SL, Horrigan JP, Dawson G, Scahill L. Lecavalier L, et al. Among authors: king bh. J Autism Dev Disord. 2014 May;44(5):1128-43. doi: 10.1007/s10803-013-1974-9. J Autism Dev Disord. 2014. PMID: 24158679 Free PMC article. Review.
Outcome measures for clinical drug trials in autism.
Aman MG, Novotny S, Samango-Sprouse C, Lecavalier L, Leonard E, Gadow KD, King BH, Pearson DA, Gernsbacher MA, Chez M. Aman MG, et al. Among authors: king bh. CNS Spectr. 2004 Jan;9(1):36-47. doi: 10.1017/s1092852900008348. CNS Spectr. 2004. PMID: 14999174 Free PMC article. Review.
Commentary from the DSM-5 Workgroup on Neurodevelopmental Disorders.
Swedo SE, Baird G, Cook EH Jr, Happé FG, Harris JC, Kaufmann WE, King BH, Lord CE, Piven J, Rogers SJ, Spence SJ, Wetherby A, Wright HH. Swedo SE, et al. Among authors: king bh. J Am Acad Child Adolesc Psychiatry. 2012 Apr;51(4):347-9. doi: 10.1016/j.jaac.2012.02.013. J Am Acad Child Adolesc Psychiatry. 2012. PMID: 22449639 No abstract available.
Exploring the manifestations of anxiety in children with autism spectrum disorders.
Hallett V, Lecavalier L, Sukhodolsky DG, Cipriano N, Aman MG, McCracken JT, McDougle CJ, Tierney E, King BH, Hollander E, Sikich L, Bregman J, Anagnostou E, Donnelly C, Katsovich L, Dukes K, Vitiello B, Gadow K, Scahill L. Hallett V, et al. Among authors: king bh. J Autism Dev Disord. 2013 Oct;43(10):2341-52. doi: 10.1007/s10803-013-1775-1. J Autism Dev Disord. 2013. PMID: 23400347 Free PMC article.
Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial.
King BH, Dukes K, Donnelly CL, Sikich L, McCracken JT, Scahill L, Hollander E, Bregman JD, Anagnostou E, Robinson F, Sullivan L, Hirtz D. King BH, et al. JAMA Pediatr. 2013 Nov;167(11):1045-52. doi: 10.1001/jamapediatrics.2013.2698. JAMA Pediatr. 2013. PMID: 24061784 Free PMC article. Clinical Trial.
STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study.
Erickson CA, Veenstra-Vanderweele JM, Melmed RD, McCracken JT, Ginsberg LD, Sikich L, Scahill L, Cherubini M, Zarevics P, Walton-Bowen K, Carpenter RL, Bear MF, Wang PP, King BH. Erickson CA, et al. Among authors: king bh. J Autism Dev Disord. 2014 Apr;44(4):958-64. doi: 10.1007/s10803-013-1963-z. J Autism Dev Disord. 2014. PMID: 24272415 Clinical Trial.
145 results